Prosetta Biosciences Stock

prosetta.comHealthcareFounded: 1900Funding to Date: $40.04MM

Prosetta Biosciences is a biotechnology company focused on developing novel small-molecule antiviral therapeutics based on Cell-Free Protein Synthesizing Systems (CFPSS).

Register for Details

For more details on financing and valuation for Prosetta Biosciences, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

By registering, you agree to the Forge Terms of Use. Already registered? Click here to log in

Enterprise Value (based on primary financings)

Enterprise Value

View Enterprise Value for Prosetta Biosciences.

Register Today

Team

Management Team

Karl Manheim
Co-Founder & Board Member
Vishwanath Lingappa Ph.D
Co-Founder, Board Member, Chief Technology Officer & Chief Executive Officer
Thomas Higgins
Founding Chief Executive & Chairman

Board Members

CJ Sylvester
Fred Alger Management
Vishwanath Lingappa Ph.D
Dale Bredesen MD
Karl Manheim
Charles Parrish
David Keys
Thomas Higgins

Other companies like Prosetta Biosciences in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.6B
Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$150MM
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$296.3MM
Sector
Last Round Est. Valuation
$4.8B

News

NEW YORK, March 28, 2017 /PRNewswire/ -- Purch, a digital publishing and marketplace platform, announced today that...